1Petersen P, Boysen G, Godtfredsen J, et al. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet,1989,1:175-179.
2Stroke prevention in atrial fibrillation investigators: stroke prevention in atrial fibrillation study final results. Circulation, 1991,84: 527-539.
3The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of lowdose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med, 1990,323:1505-1511.
4Ezekowitz MD, Bridgers SL, James KE, et al. Wafarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med, 1992,327:1406-1412.
5Connolly SJ, Laupacis A, Gent M, et al. Canadian atrial fibrillation anticoagulation (CAFA) study. J AM Coll Cardiol, 1991,18:349-355.
6The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002,347:1825-1833.
7Jais P, Haissaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation.Circulation, 1997,95: 572-576.
8Tsai CF, Tai CT, Chen SA. Pulmonary vein ablation: role in preventing atrial fibrillation. Current Opinion in Cardiology, 2003,18: 39-46.
9Faik RH. Atrial fibrillation. N Engl J Med, 2001,344:1067-1078.
10Levy S, Camm AJ, Saksena S, et al. International consensus on nomenclature and classification of atrial fibrillation: a collaborative project of the working group on arrhythmias and the working group of cardiac pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardio Electrophysio, 2003,14: 443-445.
